Rob is Managing Director, sub-Saharan Africa at Oximio, which includes operations in South Africa and the newly opened facility in Kenya. Both are licensed pharmaceutical distribution warehouses, specialising in global clinical trial supply procurement, comparator sourcing, repackaging, storage and distribution.

​

Oximio, previously known as the SMO Group, has a rapidly expanding GxP storage and services network focused on Eastern Europe, the Middle East and Africa. Along with the two facilities in serving the sub-Saharan region, Oximio also operates through a partner depot in Egypt in Africa.

 

Oximio in Kenya runs a bonded depot, and serves as a gateway to East, Central and West Africa. This enables  cost-effective solutions and quick turnaround times in the region and substantially improves patient access to medicine, particularly in difficult to reach areas and marginalised populations.

 

Rob’s background

Rob entered the clinical trial logistics market in 2002 and continues to build and maintain mutually beneficial relationships with local and international sponsors, manufacturers, and other key study stakeholders including regulators and CROs.

As a leader, team player and brand ambassador, and through Oximio’s clients, Rob is proud of the wider range of clinical research being attracted into sub-Saharan Africa.

​

Please feel free to contact Rob directly:

​

Mobile: +27 (0) 815811290

Email: rob.vdbergh@smo-group.com